Adult acute myeloid leukemia 
Age: ≥18 and ≤ 60 
Clinical condition of the patient allows to carry out induction therapy: ECOG performance status: ≤ 2 and the Hematopoietic Cell Transplant-Co-morbidity Index (HCT-I): ≤3 
Informed consent to participate in the study (ICF signed) 
The second early induction start criteria is in addition to the listed above, the percentage of the blasts on the level >10% on 7th day. 
